InnovAge (INNV)
Runs PACE centers that coordinate medical and support care for frail seniors.
$9.15
vs last close−1.50 (−14.12%)
In millions of USD, except per-share figures
| In millions | Q1 FY24Sep 2023 | Q2 FY24Dec 2023 | Q3 FY24Mar 2024 | Q4 FY24Jun 2024 | Q1 FY25Sep 2024 | Q2 FY25Dec 2024 | Q3 FY25Mar 2025 | Q4 FY25Jun 2025 | Q1 FY26Sep 2025 | Q2 FY26Dec 2025 | Q3 FY26Mar 2026 | Q4 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 182 | 189 | 193 | 199 | 205 | 209 | 218 | 218 | 236 | 240 | 252 | 262 |
| Cost of revenue | 155 | 155 | 159 | 163 | 171 | 172 | 177 | 177 | 185 | 192 | 196 | 206 |
| Gross profit | 28 | 34 | 34 | 37 | 35 | 37 | 41 | 41 | 51 | 48 | 56 | 56 |
| 39 | 35 | 40 | 41 | 39 | 50 | 51 | 51 | 43 | 32 | 33 | 40 | |
| 34 | 31 | 35 | 36 | 34 | 36 | 46 | 46 | 38 | 35 | 85 | 43 | |
| Selling & marketing | 5 | 6 | 7 | 7 | 6 | 8 | 7 | 7 | 8 | 8 | 9 | 10 |
| General & administrative | 29 | 25 | 28 | 30 | 28 | 28 | 39 | 39 | 30 | 27 | 77 | 33 |
| Other expenses | 4 | 4 | 5 | 5 | 5 | 14 | 5 | 5 | 5 | −3 | −52 | −3 |
| Operating income | −11 | −2 | −6 | −5 | −5 | −13 | −10 | −10 | 8 | 16 | 23 | 16 |
| 0 | −2 | −1 | 4 | 0 | −1 | −1 | −1 | 0 | −4 | −53 | −6 | |
| Interest expense | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Other non-operating income | −1 | 1 | 0 | −5 | −1 | 0 | 0 | 0 | −1 | 2 | 52 | 0 |
| Income before tax | −11 | −4 | −6 | −1 | −5 | −13 | −11 | −11 | 8 | 12 | −30 | 10 |
| Income tax expense | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Net income from continuing operations | −11 | −4 | −6 | −2 | −6 | −13 | −11 | −11 | 8 | 12 | −30 | 10 |
| Net income | −10 | −3 | −6 | −2 | −5 | −13 | −11 | −11 | 8 | 11 | −29 | 8 |
| EPS, basic | −$0.08 | −$0.03 | −$0.04 | −$0.01 | −$0.04 | −$0.10 | −$0.08 | −$0.08 | $0.06 | $0.08 | −$0.22 | $0.06 |
| EPS, diluted | −$0.08 | −$0.03 | −$0.04 | −$0.01 | −$0.04 | −$0.10 | −$0.08 | −$0.08 | $0.06 | $0.08 | −$0.22 | $0.06 |
| Weighted average shares, basic | 136 | 136 | 136 | 136 | 136 | 135 | 135 | 135 | 135 | 136 | 136 | 136 |
| Weighted average shares, diluted | 136 | 136 | 136 | 136 | 136 | 135 | 135 | 135 | 135 | 136 | 136 | 137 |
| EBITDA | −6 | 1 | 0 | 6 | 1 | −7 | −5 | −5 | 14 | 19 | −24 | 22 |
| Depreciation & amortization | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 6 |
| EBIT | −10 | −3 | −5 | 0 | −4 | −13 | −10 | −10 | 9 | 14 | −29 | 16 |
